(Q36910280)

17 August 2017

TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3 (English)

1 reference

17 August 2017

1 reference

4

Frits van Rhee

0 references

Bart Barlogie

11

object named as

Bart Barlogie

1 reference

17 August 2017

7

Sarah Waheed

1 reference

17 August 2017

5

Elias Anaissie

1 reference

17 August 2017

John D Shaughnessy

1

1 reference

17 August 2017

Yiming Zhou

2

1 reference

17 August 2017

Jeff Haessler

3

1 reference

17 August 2017

Bijay Nair

6

1 reference

17 August 2017

Yazan Alsayed

8

1 reference

17 August 2017

Joshua Epstein

9

1 reference

17 August 2017

John Crowley

10

1 reference

17 August 2017

language of work or name

English

0 references

publication date

21 August 2009

1 reference

British Journal of Haematology

17 August 2017

1 reference

17 August 2017

147

1 reference

17 August 2017

3

1 reference

17 August 2017

347-351

1 reference

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675654

Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675654

Proteasome function is required for DNA damage response and fanconi anemia pathway activation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675654

The molecular classification of multiple myeloma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675654

Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675654

The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675654

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675654

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675654

Genetics and cytogenetics of multiple myeloma: a workshop report

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675654

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675654

Treatment of multiple myeloma

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19702643

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2141.2009.07864.X

1 reference

release_6ql7ps2xfvdi3assdhmzscqm4y

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6ql7ps2xfvdi3assdhmzscqm4y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

17 August 2017

PubMed publication ID

19702643

1 reference